Aprea Therapeutics (APRE) Stock Chart & Stock Price History → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free APRE Stock Alerts $4.77 +0.16 (+3.47%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends Aprea Therapeutics Stock Price Performance5 Day Performance-4.02%1 Month Performance-12.48%3 Month Performance-40.38%6 Month Performance+31.04%Year-To-Date Performance+1.49%1 Year Performance+32.12% Receive APRE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aprea Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. APRE Stock Chart for Sunday, June, 2, 2024 APRE Chart by TradingView Aprea Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$4.57$4.77+4.38%$4.77$4.505,197 shs$25.90 million05/30/2024$4.70$4.57-2.77%$4.85$4.5411,366 shs$24.82 million05/29/2024$4.97$4.70-5.43%$4.97$4.5520,125 shs$25.52 million05/28/2024$5.30$4.97-6.23%$5.22$4.9219,634 shs$26.99 million05/27/2024$5.30$5.30+0.02%$5.30$5.194,600 shs$28.78 million05/24/2024$5.02$5.19+3.33%$5.30$5.064,691 shs$28.18 million Get the Latest News and Ratings for APRE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aprea Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$5.03$5.02-0.14%$5.02$5.02950 shs$27.27 million05/22/2024$5.09$5.03-1.18%$5.20$4.9416,256 shs$27.31 million05/21/2024$5.35$5.09-4.86%$5.29$5.0012,867 shs$27.64 million05/20/2024$5.27$5.35+1.52%$5.42$5.252,533 shs$29.05 million05/17/2024$5.46$5.27-3.48%$5.70$5.277,979 shs$28.62 million05/16/2024$5.80$5.46-5.86%$5.90$5.3314,741 shs$29.65 million05/15/2024$5.89$5.80-1.53%$5.88$5.5611,440 shs$31.49 million05/14/2024$5.59$5.89+5.37%$5.90$5.548,820 shs$31.98 million05/13/2024$5.59$5.59$5.59$5.259,969 shs$30.35 million05/10/2024$5.50$5.22-5.09%$5.67$5.1611,132 shs$28.35 million05/09/2024$5.14$5.50+7.11%$5.60$5.0534,221 shs$29.87 million05/08/2024$5.17$5.14-0.68%$5.30$5.053,818 shs$27.88 million05/07/2024$5.26$5.17-1.71%$5.35$5.175,137 shs$28.07 million05/06/2024$5.35$5.26-1.68%$5.35$5.253,460 shs$28.56 million05/03/2024$5.45$5.35-1.83%$5.45$5.352,249 shs$29.05 million05/02/2024$5.25$5.45+3.81%$5.45$5.332,195 shs$29.59 million05/01/2024$5.10$5.25+2.94%$5.25$5.102,971 shs$28.51 million04/30/2024$5.08$5.10+0.31%$5.17$4.9014,870 shs$27.69 million04/29/2024$5.20$5.08-2.23%$5.26$5.002,551 shs$27.61 million04/26/2024$5.35$5.20-2.80%$5.20$5.004,833 shs$28.24 million04/25/2024$5.07$5.35+5.52%$5.47$5.029,079 shs$29.05 million04/24/2024$5.37$5.07-5.59%$5.37$5.066,305 shs$27.53 million04/23/2024$5.16$5.37+4.07%$5.62$5.142,607 shs$29.16 million04/22/2024$5.35$5.16-3.55%$5.75$5.1211,827 shs$28.02 million04/19/2024$5.84$5.41-7.36%$5.79$5.317,280 shs$29.38 million04/18/2024$5.73$5.84+1.92%$5.84$5.61873 shs$31.71 million04/17/2024$5.70$5.73+0.53%$5.85$5.712,289 shs$31.11 million04/16/2024$5.93$5.70-3.88%$5.95$5.705,097 shs$30.95 million04/15/2024$5.71$5.93+3.85%$6.01$5.718,448 shs$32.20 million04/12/2024$5.90$5.93+0.51%$6.23$5.694,652 shs$32.20 million04/11/2024$6.20$5.90-4.84%$6.16$5.853,480 shs$32.04 million04/10/2024$6.04$6.20+2.66%$6.20$5.326,281 shs$33.67 million04/09/2024$5.84$6.04+3.41%$6.31$5.906,614 shs$32.79 million04/08/2024$6.30$5.84-7.30%$6.40$5.8211,661 shs$31.71 millionWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector… (Ad)Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Congress shifting their stocks in a frenzy? And why are they all piling into ONE unique corner of the market…Click here for the details04/05/2024$6.17$6.30+2.11%$6.48$6.009,848 shs$23.56 million04/04/2024$6.31$6.17-2.22%$6.48$6.0116,915 shs$23.08 million04/03/2024$6.60$6.31-4.39%$6.70$6.3010,211 shs$23.60 million04/02/2024$6.63$6.60-0.45%$6.60$6.2110,056 shs$24.68 million04/01/2024$6.69$6.63-0.90%$6.64$6.134,887 shs$24.80 million03/29/2024$6.69$6.69$6.80$5.9128,785 shs$25.02 million03/28/2024$6.07$6.69+10.21%$6.80$5.9128,419 shs$25.02 million03/27/2024$5.92$6.07+2.53%$6.31$5.9516,742 shs$22.70 million03/26/2024$6.08$5.92-2.63%$6.12$5.9210,133 shs$22.14 million03/25/2024$6.12$6.08-0.65%$6.20$5.9510,833 shs$22.74 million03/22/2024$6.35$6.12-3.62%$6.20$6.005,207 shs$22.89 million03/21/2024$6.50$6.35-2.31%$6.63$5.8851,594 shs$23.75 million03/20/2024$6.74$6.50-3.56%$6.74$6.484,024 shs$24.31 million03/19/2024$6.55$6.74+2.90%$6.88$6.5515,769 shs$25.21 million03/18/2024$6.19$6.55+5.82%$6.79$5.7928,291 shs$24.50 million03/15/2024$5.43$6.19+14.00%$6.20$5.5833,864 shs$23.15 million03/14/2024$5.55$5.43-2.16%$5.87$5.0528,241 shs$20.29 million03/13/2024$6.16$5.55-9.90%$6.26$5.5526,363 shs$20.74 million03/12/2024$6.77$6.16-9.01%$6.76$6.1651,852 shs$23.04 million03/11/2024$7.13$6.77-5.05%$8.10$6.271.15 million shs$25.32 million03/08/2024$7.45$7.13-4.30%$7.63$7.094,081 shs$26.67 million03/07/2024$8.29$7.45-10.13%$8.40$7.4028,563 shs$27.86 million03/06/2024$8.17$8.29+1.47%$8.29$8.091,782 shs$31.01 million03/05/2024$8.40$8.17-2.74%$8.40$7.3013,162 shs$30.56 million03/04/2024$8.00$8.40+5.00%$8.40$7.657,414 shs$31.42 million03/01/2024$8.46$8.00-5.44%$8.85$7.7228,900 shs$29.92 million Related Companies: FBRX Stock Chart CLRB Stock Chart BYSI Stock Chart CLSD Stock Chart PMVP Stock Chart VSTM Stock Chart LFVN Stock Chart PRPH Stock Chart ASRT Stock Chart TLSA Stock Chart Receive APRE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aprea Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:APRE) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport SocietyNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aprea Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.